Trial Profile
A proof-of-concept study of vanoxerine in patients with atrial fibrillation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2011
Price :
$35
*
At a glance
- Drugs Vanoxerine (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 23 Nov 2011 New trial record